SCHEMBL622332

SCHEMBL622332

CCN(CC)c1nc(-n2cccn2)nc2cc(F)c(N3CCCCC3)cc12

nearest known ligand 0.45

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 11/20 0.45
ADORA2A P29274 3/20 0.39
BCHE P06276 1/20 0.35
ACHE P22303 1/20 0.35
IP6K1 Q92551 1/20 0.35
LMNA P02545 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27901523 0.88 EGLN1 (0.45) EGLN1ADORA2ABCHEACHE
SCHEMBL623390 0.82 ADORA2A (0.52) EGLN1ADORA2AIP6K1LMNAHTT
SCHEMBL626904 0.82 EGLN1 (0.66) EGLN1ADORA2A
SCHEMBL622935 0.79 EGLN1 (0.73) EGLN1
SCHEMBL14992287 0.79 EGLN1 (0.48) EGLN1ADORA2AHTT
SCHEMBL627008 0.77 HTT (0.50) EGLN1ADORA2ALMNAHTT
SCHEMBL14992371 0.77 EGLN1 (0.49) EGLN1HTT
SCHEMBL27901534 0.76 ADORA2A (0.43) EGLN1ADORA2ALMNAHTT
SCHEMBL14992102 0.76 EGLN1 (0.40) EGLN1ADORA2ALMNAHTT
SCHEMBL28802325 0.76 ADORA2A (0.47) EGLN1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2603502-A1 4 - AMINOQUINAZOLIN- 2 - YL - 1 - PYRRAZOLE - 4 - CARBOXYLIC ACID COMPOUNDS AS PROLYL HYDROXYLASE INHIBITORS Janssen Pharmaceutica, N.V. (BE) 2013-06-19 EP disclosed
CN-103068821-A 4 - aminoquinazolin- 2 - yl - 1 - pyrrazole - 4 - carboxylic acid compounds as prolyl hydroxylase inhibitors JANSSEN PHARMACEUTICA NV 2013-04-24 CN disclosed
WO-2012021830-A1 4 - AMINOQUINAZOLIN- 2 - YL - 1 - PYRRAZOLE - 4 - CARBOXYLIC ACID COMPOUNDS AS PROLYL HYDROXYLASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2012-02-16 WO disclosed